While this limitation of our breast cancer cell line models may simplify our mechanistic understanding of luminal serine auxotrophy, low PSAT1 and low PHGDH would likely result in an even stronger serine auxotrophy phenotype in human breast tumors. This evidence concerns the gene PSAT1 and breast carcinoma.